This Progressive Professor Is Taking On The Establishment

August 29, 2017
Jeff Waldorf

Paul Clements is a professor who is running to unseat Republican Fred Upton in the 2018 midterm elections. He's a progressive who was endorsed by Bernie Sanders in his previous run, and he sits down with Jeff Waldorf to talk about the issues.

Americans Pay More For Prescription Drugs Because Our Politicians Take Bribes From Pharmaceutical Companies

August 10, 2017
Howie Klein

And then Paul Clements, the southwest Michigan progressive running for the seat occupied by one of Big Pharma's best friends, Fred Upton, told us that "If elected to Congress I will support Bernie Sanders’ and Angus King’s Affordable and Safe Prescription Drug Importation Act. My opponent, Congressman Fred Upton, helped to create the conditions that let drug companies get away with highway robbery against Americans when we are most vulnerable: when we are sick. He has sponsored legislation making it illegal to import generics from Canada and other countries-- even if they are just as safe as locally produced versions. This is some of the legislation the Sanders-King bill would overturn. And in return Upton has benefited handsomely in campaign contributions from the Big Pharma. This is, sadly, yet another example of how money in politics undermines our democracy, hurts working people, transfers our money to the 1%, and, by raising the cost of health care, undermines the competitiveness of our economy. Money in politics is turning (has turned?) America into a plutocracy. We need to combat price gouging by pharmaceutical companies, and we need deep and comprehensive campaign finance reform. In Congress this will be part of my mission."

Continue reading »

Paul Clements announces third challenge to Fred Upton in 2018

July 6, 2017
Malachi Barrett

"Clements said the health care system in broken, but Republican solutions do little more than raise costs, gift tax cuts to multimillionaires and take health care away from 40,000 people in Michigan's 6th district."

Continue reading »